Device FreeO2 v2.0
Device- Automatic adjustment of oxygen through the "Free O2" device.
- "FreeO2" device in mode medical data collecting(SpO2,EtCO2...).
NCT Number: NCT02027181
Aim: The purpose of this study is to evaluate the use feasibility of FreeO2 so as to deliver automatically oxygen in the emergency department in a patient population admitted for acute respiratory failure.
Hypothesis: The principal hypothesis is that FreeO2 is possible and well-accepted by nurses and medical personnel and there are advantages to use this system. In comparison with the common oxygen delivery (the rotameter), the hypothesis is that FreeO2 system will make for a better control of the oxygen saturation in function of designed target, reducing the desaturation time and hyperoxia. We think that oxygen weaning will be faster than classical way if it is automated. In addition, FreeO2 could reduce the number of intervention by nurse personnel.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1
Hopital Hotel Dieux de Levis, Lévis, Quebec, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 hours or 1 hour after after cessation of oxygenation
The target zone of oxygen saturation is : SpO2 = 92-96% The "acute phase of treatment" is defined by the 3 first hours of treatment by oxygenation and/or until one hour after the end of this last.
Time frame: 3 days max
Time frame: 3 hours or 1 hour after after cessation of oxygenation
Time frame: 3 hours or 1 hour after after cessation of oxygenation
Time frame: 3 hours or 1 hour after after cessation of oxygenation
Time frame: 28 days max
Time frame: 28 days max
Time frame: 28 days max
University Hospital, Brest
Other
Automation of the Oxygen's Administration in Spontaneous Ventilation (FreeO2) During the Hypoxemic Acute Respiratory Distress
Acronym: FreeO2-Hypox
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04998253
Acute Respiratory Distress Syndrome, Hypoxemia
Mexico City, Mexico
View Trial DetailsNCT02450825
Acute Respiratory Distress Syndrome, Atelectasis
Montreal, Quebec, Canada
View Trial DetailsNCT02010073
Acute Respiratory Distress Syndrome, Acute Severe Respiratory Failure
Brussels, Belgium
View Trial DetailsNCT00538928
Acute Respiratory Distress Syndrome, Hypercapnia
Regensburg, Germany
View Trial Details